Liu C, Wu T, Ren N (2023) Glucagon-like peptide-1 receptor agonists for the management of diabetic peripheral neuropathy
doi: 10.1186/s13148-020-00837-1 296 GilbertWVBellTASchaeningC
Design should match ionizable motifs or acid sensitive chemistries to the OA pH range and tune crosslink density to remain stable at physiological pH yet respond under mild acidity
In addition, a study using LPS-exposed RAW264.7 macrophages and a DSS-triggered colitis murine model demonstrated that GLP-1 attenuates inflammatory responses by inhibiting the phosphorylation process of AKT/NF-B and MAPK signal-transducing molecules under in vitro and in vivo circumstances, respectively [219]
And research shows that sulforaphane can decrease neuroinflammation.[8] Sulforaphane also has neuroprotective benefits
Risks: Increased heart rate, potential worsening of heart failure with reduced ejection fraction, and rare complications like hypoglycemia or retinopathy